Open in app
Foresite Capital Viewpoints
Foresite Capital Viewpoints
Sign inGet started
Archive of stories published by Foresite Capital Viewpoints
All
Go to the profile of R. Scott McIsaac, Ph.D.
R. Scott McIsaac, Ph.D. in Foresite Capital Viewpoints
Read more…
Go to the profile of Foresite Capital
Foresite Capital in Foresite Capital Viewpoints
Read more…
Go to the profile of Foresite Capital
Foresite Capital in Foresite Capital Viewpoints

Introducing Our New Look

By Jim Tananbaum, Founder, CEO & Managing Director

Read more…
Go to the profile of Cindy Xiong
Cindy Xiong in Foresite Capital Viewpoints

New hope for cancer patients with no other treatment options

Today we are pleased to announce Foresite Capital’s investment in ImmPACT Bio, which we co-led with Venbio and Decheng Capital. We’re excited about ImmPACT’s focus on next generation cancer therapies based on transformative…

Read more…

About
Foresite Capital Viewpoints
Foresite Capital is a multi-stage healthcare and life sciences investment firm with ~$4 billion under management. The firm aims to address areas of great unmet need by funding promising healthcare and life sciences businesses at all stages.
More information
Tags
Car T Cell Therapy
Healthcare
Venture Capital
Cancer
Logo Design
Branding
Precision Medicine
Venture Capital
Healthcare
Life Sciences
Editors
Go to the profile of Foresite Capital
Foresite Capital
Go to the profile of Dr. Vikram (Vik) Bajaj
Dr. Vikram (Vik) Bajaj
Writers
Go to the profile of Dr. Vikram (Vik) Bajaj
Dr. Vikram (Vik) Bajaj
Go to the profile of Foresite Capital
Foresite Capital
Go to the profile of Jim Tananbaum
Jim Tananbaum
Go to the profile of Cindy Xiong
Cindy Xiong
Go to the profile of R. Scott McIsaac, Ph.D.
R. Scott McIsaac, Ph.D.
Go to the profile of Alyssa Jarvi
Alyssa Jarvi